Mangoceuticals (MGRX) Change in Inventory (2023 - 2024)
Mangoceuticals' (MGRX) quarterly Change in Inventory came in at -$806.0 in Q3 2024, up 57.87% year-on-year from -$510.56 in Q4 2023, and down 86.14% quarter-over-quarter from -$433.0 in Q2 2024.
Mangoceuticals (MGRX) Change in Inventory (2023 - 2024) Analysis & Trends
Mangoceuticals has disclosed Change in Inventory across 2 years of filings, most recently posting -$806.0 for Q3 2024.
- Change in Inventory for Q3 2024 came in at -$806.0, up 57.87% year-over-year; the trailing twelve-month figure through Sep 2024 was -$8368.0 (changed N/A YoY), and the FY2023 annual result was $18501.0, changed N/A from the prior year.
- Change in Inventory came in at -$806.0 for Q3 2024 at Mangoceuticals, down from -$433.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of -$433.0 in Q2 2024 to a low of -$4049.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | -254.83 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | -1.47 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -2.70 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | - |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | - |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | -1.70 Mn |
| 10 | Mangoceuticals | 5.25 Mn | 5.06 Mn | 29,001.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -806.00 |
| Sep 30, 2024 | -806.00 |
| Jun 30, 2024 | -433.00 |
| Jun 30, 2024 | -433.00 |
| Mar 31, 2024 | -4,049.00 |
| Mar 31, 2024 | -4,049.00 |
| Dec 31, 2023 | -3,080.00 |
| Dec 31, 2023 | -3,080.00 |
| Sep 30, 2023 | -1,913.00 |
| Sep 30, 2023 | -1,913.00 |